Uncategorized

FDA Medical Device Facility Registration, Device Listing & UDI Assignment in EGYPT

Published on October 15, 2026 By

Navigating the complex corridor between Egyptian medical device manufacturing and the United States healthcare market requires stringent regulatory synchronization. Water Chemicals Solution (Alkemist) provides end-to-end regulatory consultancy, ensuring Egyptian manufacturers, contract packagers, sterilizers, and exporters achieve seamless compliance with the United States Food and Drug Administration (US FDA). We manage your FDA Medical Device Facility Registration, Device Listing, and Unique Device Identification (UDI) implementation with precision and complete regulatory integrity.

Applicable Regulations in EGYPT

Medical device manufacturers operating within the Arab Republic of Egypt are primarily governed domestically by the Egyptian Drug Authority (EDA) under Law No. 151 of 2019 and relevant Central Administration for Medical Devices guidelines. However, when entering the international supply chain targeting the United States, local manufacturers must align their quality management systems and data governance with Title 21 of the US Code of Federal Regulations (CFR):

  • 21 CFR Part 807 – Establishment Registration and Device Listing: Foreign manufacturers, repackagers, and relabelers located in Egypt must register their physical facilities and list every device intended for commercial distribution in the US prior to export.
  • 21 CFR Part 830 & Part 801.20 – Unique Device Identification (UDI): Mandatory assignment of globally unique identifiers consisting of a Device Identifier (DI) and Production Identifier (PI), alongside complete data submission to the FDA’s Global Unique Device Identification Database (GUDID).
  • 21 CFR Part 807 Subpart C – US Designated Agent: Egyptian establishments must legally appoint an official US Agent residing or maintaining a place of business in the United States to act as the primary liaison with the FDA for inspections and urgent queries.
  • Harmonization with ISO 13485:2016 & EDA Clearances: Ensuring export declarations, domestic manufacturing licenses, and Certificate of Free Sale (CFS) from Egypt align coherently with US FDA premarket submissions, 510(k) clearances, or PMA pathways.

What We Deliver for EGYPT

At Alkemist, we eliminate the administrative and technical friction of US market entry for Egyptian enterprises. Our comprehensive compliance suite guarantees accuracy, speed, and regulatory acceptance:

  • Facility Registration & FDA User Fee Navigation: Rapid procurement of your Data Universal Numbering System (DUNS) code, FDA Establishment Identifier (FEI), and management of the annual Medical Device User Fee Amendments (MDUFA) payment schedules.
  • Comprehensive Device Listing: Classification and listing of Class I, Class II, and Class III medical devices, in vitro diagnostics (IVDs), and combination products under the appropriate FDA Product Codes and Premarket Notification numbers.
  • UDI Architecture & GUDID Integration: End-to-end allocation of GS1 or HIBCC standards, human-readable interpretation (HRI), barcode verification, and direct transmission of device attributes to the FDA AccessGUDID portal.
  • Fast Turnaround Times: Accelerated regulatory processing workflows that expedite listing verification to prevent logistical stagnation at domestic and international checkpoints.
  • Localized Language Variants: Technical translation and bilingual alignment (Arabic/English) of instructions for use (IFU), packaging, and technical files, ensuring zero semantic discrepancy between EDA dossiers and US FDA labeling rules.
  • Export-Ready Files: Consolidated regulatory documentation packages, commercial compliance declarations, and verified listing certificates tailored for immediate presentation to customs brokers, freight forwarders, and trade authorities.

Local Challenges We Solve

Operating out of manufacturing hubs such as 10th of Ramadan City, 6th of October City, Alexandria, or the Suez Canal Economic Zone presents unique cross-border friction points. Alkemist actively mitigates these operational vulnerabilities:

  • Eliminating Customs Delays: Shipments departing major Egyptian ports (Port Said, Alexandria, Sokhna) or Cairo International Airport Cargo Village frequently face severe delays or entry refusal at US ports of entry due to listing discrepancies, inactive FEI numbers, or missing UDI barcodes. We secure flawless pre-clearance verification.
  • Resolving Hazard Phrasing Differences: Discrepancies between local Egyptian labeling conventions, GHS (Globally Harmonized System) standards, and US FDA/OSHA hazard statement phraseology can trigger regulatory enforcement. We harmonize warning statements, biocompatibility claims, and device classifications to adhere strictly to FDA requirements.
  • US Agent Representation: Egyptian entities often lack an authorized, legally registered representative within the United States. Alkemist provides a dedicated US regulatory agent capable of handling 24/7 FDA inquiries, facility inspection notices, and official communications.
  • DUNS Entity Data Mismatches: Structural differences in Egyptian commercial registry entries compared to Dun & Bradstreet formatting regularly stall FDA registration systems. We rectify entity mapping to prevent institutional processing holds.

Start Your Request

Position your medical device manufacturing operations for uninterrupted trade with the United States. Contact the regulatory affairs team at Water Chemicals Solution (Alkemist) today for an evaluation of your device portfolio, UDI onboarding, and facility compliance roadmap.

Submit your inquiry directly to our senior regulatory compliance specialists at: admin@alkemist.org